| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |